Karachi, Sanofi Aventis Pakistan Limited has announced the retirement of Dr. Asim Jamal, the current Managing Director & CEO of the company, effective June 30, 2023. Dr. Jamal’s departure marks the end of a distinguished tenure, during which he made significant contributions to the company. The Board of Directors expressed their gratitude for his valuable services and extended their best wishes for his future endeavors.
Following Dr. Jamal’s retirement, the Board of Directors has appointed Mr. Sajjad Iftikhar as the new CEO of Sanofi Aventis Pakistan Limited. However, the appointment is subject to compliance with all relevant laws, rules, and regulations governing such appointments.
Mr. Iftikhar brings a wealth of experience and expertise to the role, having served in various leadership positions in the pharmaceutical industry. His extensive knowledge of the industry and strategic vision make him a suitable candidate for leading Sanofi Aventis Pakistan Limited in the next phase of its growth.
As the new CEO, Mr. Iftikhar will be responsible for overseeing the company’s operations, driving its strategic initiatives, and ensuring the continued delivery of high-quality healthcare products to patients across Pakistan. His appointment reflects the company’s commitment to maintaining a strong leadership team and fostering a culture of excellence.
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service